Scholarlink

<p>Fifteen years have elapsed since the publication of the seminal work establishing the association between risk variants in the Apolipoprotein L1 (<i>APOL1</i>) gene and kidney disease in individuals of African ancestry. During this period, substantial advancements have been achieved in elucidating the pathophysiology of APOL1-mediated kidney disease, leading to the development of promising therapeutic strategies. In this review, we summarize the key molecular mechanisms driving this disease, including modifiers of onset and progression, and explore relevant disease models. Furthermore, we discuss current therapeutic approaches and outline future research directions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

APOL1-mediated kidney disease: a narrative review of the lessons learnt from the past 15 years

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月17日

查看全文
  • Oyindamola Christiana Adebayo,
  • Henry Chijindu Okpoli,
  • Joris Vriens,
  • Elena Levtchenko,
  • Lambertus van den Heuvel,
  • Veerle Labarque

摘要

Fifteen years have elapsed since the publication of the seminal work establishing the association between risk variants in the Apolipoprotein L1 (APOL1) gene and kidney disease in individuals of African ancestry. During this period, substantial advancements have been achieved in elucidating the pathophysiology of APOL1-mediated kidney disease, leading to the development of promising therapeutic strategies. In this review, we summarize the key molecular mechanisms driving this disease, including modifiers of onset and progression, and explore relevant disease models. Furthermore, we discuss current therapeutic approaches and outline future research directions.